SCHEMBL321068

SCHEMBL321068

CC1(C)NC(C(=O)O)Cc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
LMNA P02545 1/20 0.47
BLM P54132 1/20 0.47
CYP3A4 P08684 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
CYP2D6 P10635 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
BCHE P06276 1/20 0.43
CHRM5 P08912 1/20 0.43
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.43
NFKB1 P19838 1/20 0.43
MAPK1 P28482 1/20 0.43
PRCP P42785 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29683348 1.00 KDM4E (0.51) KDM4EGAAMAPTLMNABLM
Hydrochloric Acid SCHEMBL322303 0.98 KDM4E (0.50) KDM4EGAAMAPTLMNABLM
SCHEMBL14355716 0.87 LMNA (0.44) KDM4EGAAMAPTLMNABLM
SCHEMBL14626660 0.87 LMNA (0.44) KDM4EGAAMAPTLMNABLM
SCHEMBL14591330 0.84 LMNA (0.42) KDM4ELMNABLMCYP3A4KMT2A
SCHEMBL14279598 0.83 BACE1 (0.43) KDM4EGAAMAPTLMNABLM
SCHEMBL5341333 0.80 KDM4E (0.42) KDM4EGAAMAPTGRIN2DGRIN3B
SCHEMBL5336592 0.80 SIGMAR1 (0.43) KDM4EMAPTCYP2D6CYP2C19MAPK1
SCHEMBL27561093 0.78 GAA (0.47) KDM4EGAAMAPTLMNABLM
SCHEMBL5382178 0.77 MTNR1A (0.40) KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7169777-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-01-30 US claimed
US-7157463-B2 Substituted piperidines/piperazines as melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-01-02 US claimed
US-20040116699-A1 Melanocortin receptor agonists ELI LILLY AND COMPANY 2004-06-17 US claimed
CN-113387874-B Method for synthesizing 6, 6-dialkyl piperidine-2-carboxylic acid compound 上海毕得医药科技股份有限公司 2022-06-24 CN disclosed
CN-113387874-A Synthesis method of 6, 6-dialkyl piperidine-2-carboxylic acid compound 上海毕得医药科技股份有限公司 2021-09-14 CN disclosed
EP-2590910-A2 FLUORINE RADIOLABELLING PROCESS Isis Innovation Limited (GB) 2013-05-15 EP disclosed
WO-2012004567-A2 FLUORINE RADIOLABELLING PROCESS ISIS INNOVATION LIMITED (GB) 2012-01-12 WO disclosed
US-7314879-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2008-01-01 US disclosed
US-7314879-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2008-01-01 US disclosed
US-7291619-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-11-06 US disclosed
US-7291619-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-11-06 US disclosed
US-7186715-B2 Piperazine- and piperidine-derivatives as melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-03-06 US disclosed
US-7186715-B2 Piperazine- and piperidine-derivatives as melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-03-06 US disclosed
US-7169777-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-01-30 US disclosed
US-7157463-B2 Substituted piperidines/piperazines as melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-01-02 US disclosed
US-7157463-B2 Substituted piperidines/piperazines as melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-01-02 US disclosed
US-20040116699-A1 Melanocortin receptor agonists ELI LILLY AND COMPANY 2004-06-17 US disclosed
EP-1358163-A1 MELANOCORTIN RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2003-11-05 EP disclosed
WO-2002059095-A1 MELANOCORTIN RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2002-08-01 WO disclosed